Citations (132)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (19)
Kaisaner Rexiti, Xuehui Jiang, Ying Kong, Xu Chen, Hong Liu, Hongwei Peng & Xiaohua Wei. (2023) Population pharmacokinetics of mycophenolic acid and dose optimisation in adult Chinese kidney transplant recipients. Xenobiotica 0:0, pages 1-10.
Read now
Read now
Akio Fujimura & Kentaro Ushijima. (2023) Understanding the role of chronopharmacology for drug optimization: what do we know?. Expert Review of Clinical Pharmacology 16:7, pages 655-668.
Read now
Read now
Yong-Jian Geng, Michael H. Smolensky, Oliver Sum-Ping, Ramon Hermida & Richard J. Castriotta. (2023) Circadian rhythms of risk factors and management in atherosclerotic and hypertensive vascular disease: Modern chronobiological perspectives of an ancient disease. Chronobiology International 40:1, pages 33-62.
Read now
Read now
Ramón C. Hermida, Artemio Mojón, José R. Fernández, Ramón G. Hermida-Ayala, Juan J. Crespo, María T. Ríos, Manuel Domínguez-Sardiña, Alfonso Otero & Michael H. Smolensky. (2023) Elevated asleep blood pressure and non-dipper 24h patterning best predict risk for heart failure that can be averted by bedtime hypertension chronotherapy: A review of the published literature. Chronobiology International 40:1, pages 63-82.
Read now
Read now
José-Ramon Blanco, Eva M. Verdugo-Sivianes, Ana Amiama & Sandra Muñoz-Galván. (2022) The circadian rhythm of viruses and its implications on susceptibility to infection. Expert Review of Anti-infective Therapy 20:8, pages 1109-1117.
Read now
Read now
Ramón G. Hermida-Ayala, Artemio Mojón, José R. Fernández, Michael H. Smolensky & Ramón C. Hermida. (2022) Ingestion-time differences in the pharmacodynamics of dual-combination hypertension therapies: Systematic review and meta-analysis of published human trials. Chronobiology International 39:4, pages 493-512.
Read now
Read now
Ramón C. Hermida, Ramón G. Hermida-Ayala, Artemio Mojón, Michael H. Smolensky & José R. Fernández. (2021) Systematic review and quality evaluation of published human ingestion-time trials of blood pressure-lowering medications and their combinations. Chronobiology International 38:10, pages 1460-1476.
Read now
Read now
Jiří Pácha, Kateřina Balounová & Matúš Soták. (2021) Circadian regulation of transporter expression and implications for drug disposition. Expert Opinion on Drug Metabolism & Toxicology 17:4, pages 425-439.
Read now
Read now
Ramón C. Hermida, Michael H. Smolensky, Horia Balan, Richard J. Castriotta, Juan J. Crespo, Yaron Dagan, Sherine El-Toukhy, José R. Fernández, Garret A. FitzGerald, Akio Fujimura, Yong-Jian Geng, Ramón G. Hermida-Ayala, Antonio P. Machado, Luiz Menna-Barreto, Artemio Mojón, Alfonso Otero, R. Daniel Rudic, Eva Schernhammer, Carsten Skarke, Tomoko Y. Steen, Martin E. Young & Xiaoyun Zhao. (2021) Guidelines for the design and conduct of human clinical trials on ingestion-time differences – chronopharmacology and chronotherapy – of hypertension medications. Chronobiology International 38:1, pages 1-26.
Read now
Read now
Ramón C. Hermida, Ramón G. Hermida-Ayala, Michael H. Smolensky, Artemio Mojón & José R. Fernández. (2020) Ingestion-time – relative to circadian rhythms – differences in the pharmacokinetics and pharmacodynamics of hypertension medications. Expert Opinion on Drug Metabolism & Toxicology 16:12, pages 1159-1173.
Read now
Read now
Zaoqin Yu, Xiping Li, Chengyang Feng, Kai Lei, Wenxi He, Chengliang Zhang & Dong Liu. (2020) Circadian variations in the pharmacokinetics of bucinnazine in rats. Biological Rhythm Research 51:5, pages 758-769.
Read now
Read now
Michael H. Smolensky, Alain E. Reinberg & Linda Sackett-Lundeen. (2017) Perspectives on the relevance of the circadian time structure to workplace threshold limit values and employee biological monitoring. Chronobiology International 34:10, pages 1439-1464.
Read now
Read now
Samira Khodadoustan, Iran Nasri Ashrafi, K Vanaja Satheesh, Chethan Kumar, Shekar HS & Chikkalingaiah S. (2017) Evaluation of the effect of time dependent dosing on pharmacokinetic and pharmacodynamics of amlodipine in normotensive and hypertensive human subjects. Clinical and Experimental Hypertension 39:6, pages 520-526.
Read now
Read now
Ichrak Dridi, Wafa Ben-Cherif, Karim Aouam, Zohra Haouas, Mossadok Ben-Attia, Alain Reinberg & Naceur A. Boughattas. (2015) Circadian variation in hepatic toxicity of the immunosuppressive agent “Mycophenolate Mofetil” in rats. Biological Rhythm Research 46:5, pages 739-751.
Read now
Read now
Hatem Sallam, Ahmed T. El-Serafi, Elisabeth Filipski, Ylva Terelius, Francis Lévi & Moustapha Hassan. (2015) The effect of circadian rhythm on pharmacokinetics and metabolism of the Cdk inhibitor, roscovitine, in tumor mice model. Chronobiology International 32:5, pages 608-614.
Read now
Read now
Mahdi Alamili, Mads Klein, Jens Lykkesfeldt, Jacob Rosenberg & Ismail Gögenur. (2013) Circadian Variation in the Response to Experimental Endotoxemia and Modulatory Effects of Exogenous Melatonin. Chronobiology International 30:9, pages 1174-1180.
Read now
Read now
Xia Li, Zhao Wang, Wei-ping Liu, Yan-gang Wang, Bing Li & Zhou Fei. (2013) Chronokinetic study of cefprozil in postprandial and fasting volunteers. Biological Rhythm Research 44:1, pages 95-102.
Read now
Read now
Yi Ding, YanYan Jia, WenXing Liu, ChengTao Lu, YanRong Zhu, Jing Yang, LiKun Ding, Lin Yang & AiDong Wen. (2012) Chronokinetic study of cefalexin in postprandial and fasting volunteers. Biological Rhythm Research 43:5, pages 505-513.
Read now
Read now
Bruce D. Butler, Tina M. Little, Robert B. Sothern & Michael H. Smolensky. (2010) CIRCADIAN STUDY OF DECOMPRESSION SICKNESS SYMPTOMS AND RESPONSE-ASSOCIATED VARIABLES IN RATS. Chronobiology International 27:1, pages 138-160.
Read now
Read now
Articles from other publishers (113)
Cheng-Yang Hsieh, Po-Wei Tsai, Yoshihisa Tomioka, Yotaro Matsumoto, Yasutoshi Akiyama, Ching-Chiung Wang, Lemmuel L. Tayo & Chia-Jung Lee. (2023) Chronopharmacology of diuresis via metabolic profiling and key biomarker discovery of the Traditional Chinese Prescription Ji-Ming-San using tandem mass spectrometry in rat models. Phytomedicine, pages 155260.
Crossref
Crossref
Yumeng Wang & Tom Deboer. (2023) Hypnotic effects of melatonin depend on the environmental lighting conditions in the rat. Journal of Pineal Research.
Crossref
Crossref
Yannuo Li, Lingjun Lu & Ioannis P. Androulakis. (2023) The Physiological and Pharmacological Significance of the Circadian Timing of the HPA Axis: A Mathematical Modeling Approach. Journal of Pharmaceutical Sciences.
Crossref
Crossref
Konstantinos C. Makris, Behzad Heibati & Shan Zienolddiny Narui. (2023) Chrono-modulated effects of external stressors on oxidative stress and damage in humans: A scoping review on night shift work. Environment International 178, pages 108048.
Crossref
Crossref
Bhavana B. Bhat, Chetan H. Mehta, Akhil Suresh, Varalakshmi Velagacherla & Usha Y. Nayak. (2023) Controlled Release Technologies for Chronotherapy: Current Status and Future
Perspectives. Current Pharmaceutical Design 29:14, pages 1069-1091.
Crossref
Crossref
Javiera Cortés-Ríos & Maria Rodriguez-Fernandez. (2023) Understanding the dosing-time-dependent antihypertensive effect of valsartan and aspirin through mathematical modeling. Frontiers in Endocrinology 14.
Crossref
Crossref
Elina Ioannou, Stavros Oikonomou, Nikolaos Efthymiou, Andria Constantinou, Thibaut Delplancke, Pantelis Charisiadis & Konstantinos C. Makris. (2023) A time differentiated dietary intervention effect on the biomarkers of exposure to pyrethroids and neonicotinoids pesticides. iScience 26:2, pages 105847.
Crossref
Crossref
Tânia Albuquerque, Ana Raquel Neves, Rúben Faria, Telma Quintela & Diana Costa. 2023. Cancer Nanotechnology. Cancer Nanotechnology
205
227
.
Yiting He, Haobin Cen, Lianxia Guo, Tianpeng Zhang, Yi Yang, Dong Dong & Baojian Wu. (2022) Circadian oscillator NPAS2 regulates diurnal expression and activity of CYP1A2 in mouse liver. Biochemical Pharmacology 206, pages 115345.
Crossref
Crossref
Yuda Turana, Robert Shen, Michael Nathaniel, Yook‐Chin Chia, Yan Li & Kazuomi Kario. (2022) Neurodegenerative diseases and blood pressure variability: A comprehensive review from HOPE Asia. The Journal of Clinical Hypertension 24:9, pages 1204-1217.
Crossref
Crossref
Fangjun Yu, Yuanyuan Liu, Rong Zhang, Lijun Zhu, Tianpeng Zhang & Yafei Shi. (2022) Recent advances in circadian-regulated pharmacokinetics and its implications for chronotherapy. Biochemical Pharmacology 203, pages 115185.
Crossref
Crossref
Mona Darwish, James M. Youakim, Jim Harlick, Daryl DeKarske & Serge Stankovic. (2022) A Phase 1, Open-Label Study to Evaluate the Effects of Food and Evening Dosing on the Pharmacokinetics of Oral Trofinetide in Healthy Adult Subjects. Clinical Drug Investigation 42:6, pages 513-524.
Crossref
Crossref
Patinee Tippayachai, Nattawut Leelakanok & Janthima Methaneethorn. (2022) Significant predictors for topiramate pharmacokinetics: a systematic review of population pharmacokinetic studies. Journal of Pharmacy Practice and Research 52:2, pages 94-107.
Crossref
Crossref
Markella I Printezi, Aoife B Kilgallen, Marinde J G Bond, Urška Štibler, Marrit Putker, Arco J Teske, Maarten J Cramer, Cornelis J A Punt, Joost P G Sluijter, Alwin D R Huitema, Anne M May & Linda W van Laake. (2022) Toxicity and efficacy of chronomodulated chemotherapy: a systematic review. The Lancet Oncology 23:3, pages e129-e143.
Crossref
Crossref
Ana R. Neves, Rúben Faria, Tânia Albuquerque, Telma Quintela, Ângela Sousa & Diana Costa. 2022. Biological Macromolecules. Biological Macromolecules
607
632
.
Marta Vázquez, R. Eiraldi & C. Maldonado. 2022. The ADME Encyclopedia. The ADME Encyclopedia
1065
1071
.
R. Eiraldi, C. Maldonado & Marta Vázquez. 2022. The ADME Encyclopedia. The ADME Encyclopedia
250
259
.
Lukasz Dobrek. (2021) Chronopharmacology in Therapeutic Drug Monitoring—Dependencies between the Rhythmics of Pharmacokinetic Processes and Drug Concentration in Blood. Pharmaceutics 13:11, pages 1915.
Crossref
Crossref
Konstantinos Christos Makris. (2021) Desynchronized circadian clock and exposures to xenobiotics are associated with differentiated disease phenotypes. BioEssays 43:11.
Crossref
Crossref
Ramón C. Hermida, Artemio Mojón, Ramón G. Hermida-Ayala, Michael H. Smolensky & José R. Fernández. (2021) Extent of asleep blood pressure reduction by hypertension medications is ingestion-time dependent: Systematic review and meta-analysis of published human trials. Sleep Medicine Reviews 59, pages 101454.
Crossref
Crossref
Tânia Albuquerque, Ana R. Neves, Telma Quintela & Diana Costa. (2021) Exploring the link between chronobiology and drug delivery: effects on cancer therapy. Journal of Molecular Medicine 99:10, pages 1349-1371.
Crossref
Crossref
Ramón C. Hermida, Artemio MojónMichael H. SmolenskyJosé R. Fernández. (2021) Lowering Nighttime Blood Pressure With Bedtime Dosing of Antihypertensive Medications: Controversies in Hypertension—Pro Side of the Argument. Hypertension 78:3, pages 879-893.
Crossref
Crossref
Yaakov Nahmias & Ioannis P. Androulakis. (2021) Circadian Effects of Drug Responses. Annual Review of Biomedical Engineering 23:1, pages 203-224.
Crossref
Crossref
Vivaswath S. Ayyar & Siddharth Sukumaran. (2021) Circadian rhythms: influence on physiology, pharmacology, and therapeutic interventions. Journal of Pharmacokinetics and Pharmacodynamics 48:3, pages 321-338.
Crossref
Crossref
Leonardo Vinícius Monteiro de Assis & Henrik Oster. (2021) The circadian clock and metabolic homeostasis: entangled networks. Cellular and Molecular Life Sciences 78:10, pages 4563-4587.
Crossref
Crossref
Amber A. Parnell, Aliza K. De Nobrega & Lisa C. Lyons. (2021) Translating around the clock: Multi-level regulation of post-transcriptional processes by the circadian clock. Cellular Signalling 80, pages 109904.
Crossref
Crossref
Ramón C. Hermida, Ramón G. Hermida-Ayala, Michael H. Smolensky, Artemio Mojón & José R. Fernández. (2021) Ingestion-time differences in the pharmacodynamics of hypertension medications: Systematic review of human chronopharmacology trials. Advanced Drug Delivery Reviews 170, pages 200-213.
Crossref
Crossref
Alíz T Y Owolabi, Sarah E Reece & Petra Schneider. (2021) Daily rhythms of both host and parasite affect antimalarial drug efficacy. Evolution, Medicine, and Public Health 9:1, pages 208-219.
Crossref
Crossref
Angélique Sadlon, Angela Ensslin, Gregor Freystätter, Michael Gagesch & Heike A Bischoff-Ferrari. (2021) Are patients with cognitive impairment fit to fly? Current evidence and practical recommendations. Journal of Travel Medicine 28:1.
Crossref
Crossref
Yong-Jian Geng, Rosalinda Madonna, Ramon C. Hermida & Michael H. Smolensky. (2021) Pharmacogenomics and circadian rhythms as mediators of cardiovascular drug-drug interactions. Current Research in Pharmacology and Drug Discovery 2, pages 100025.
Crossref
Crossref
Devendra Choudhary, Hanmant Goykar, Kuldeep Rajpoot & Rakesh Kumar Tekade. 2021. Biopharmaceutics and Pharmacokinetics Considerations. Biopharmaceutics and Pharmacokinetics Considerations
163
194
.
Nupur Vasdev, Kuldeep Rajpoot & Rakesh Kumar Tekade. 2021. Biopharmaceutics and Pharmacokinetics Considerations. Biopharmaceutics and Pharmacokinetics Considerations
415
449
.
Beata Krasińska, Lech Paluszkiewicz, Ewa Miciak-Ławicka, Maciej Krasinski, Piotr Rzymski, Andrzej Tykarski & Zbigniew Krasiński. (2020) The impact of acetylsalicylic acid dosed at bedtime on circadian rhythms of blood pressure in the high-risk group of cardiovascular patients—a randomized, controlled trial. European Journal of Clinical Pharmacology 77:1, pages 35-43.
Crossref
Crossref
M. Vázquez, R. Eiraldi & C. Maldonado. 2021. The ADME Encyclopedia. The ADME Encyclopedia
1
7
.
R. Eiraldi, C. Maldonado & M. Vázquez. 2021. The ADME Encyclopedia. The ADME Encyclopedia
1
10
.
Danyi Lu, Mengjing Zhao, Min Chen & Baojian Wu. (2020) Circadian Clock–Controlled Drug Metabolism: Implications for Chronotherapeutics. Drug Metabolism and Disposition 48:5, pages 395-406.
Crossref
Crossref
Gianluigi Mazzoccoli, Manlio Vinciguerra, Annalucia Carbone & Angela Relógio. (2020) The Circadian Clock, the Immune System, and Viral Infections: The Intricate Relationship Between Biological Time and Host-Virus Interaction. Pathogens 9:2, pages 83.
Crossref
Crossref
Megerle L. Scherholz, Naomi Schlesinger & Ioannis P. Androulakis. (2019) Chronopharmacology of glucocorticoids. Advanced Drug Delivery Reviews 151-152, pages 245-261.
Crossref
Crossref
Laetitia S. Gaspar, Ana Rita Álvaro, Sara Carmo‐Silva, Alexandrina Ferreira Mendes, Angela Relógio & Cláudia Cavadas. (2019) The importance of determining circadian parameters in pharmacological studies. British Journal of Pharmacology 176:16, pages 2827-2847.
Crossref
Crossref
Hongxia Zhang, Siyang Lin, Xudong Chen, Lei Gu, Xiaohong Zhu, Yinuo Zhang, Kassandra Reyes, Brian Wang & Kunlin Jin. (2019) The effect of age, sex and strains on the performance and outcome in animal models of stroke. Neurochemistry International 127, pages 2-11.
Crossref
Crossref
Richard G. Carroll, George A. Timmons, Mariana P. Cervantes-Silva, Oran D. Kennedy & Annie M. Curtis. (2019) Immunometabolism around the Clock. Trends in Molecular Medicine 25:7, pages 612-625.
Crossref
Crossref
Atish Mukherji, Shannon M. Bailey, Bart Staels & Thomas F. Baumert. (2019) The circadian clock and liver function in health and disease. Journal of Hepatology 71:1, pages 200-211.
Crossref
Crossref
Marleen Buurma, Jeske J. K. van Diemen, Abel Thijs, Mattijs E. Numans & Tobias N. Bonten. (2019) Circadian Rhythm of Cardiovascular Disease: The Potential of Chronotherapy With Aspirin. Frontiers in Cardiovascular Medicine 6.
Crossref
Crossref
Martine Géhin, Dominik Lott, Hervé Farine, Milena Issac, Daniel Strasser, Patricia Sidharta & Jasper Dingemanse. (2019) Pharmacokinetics, pharmacodynamics, tolerability and prediction of clinically effective dose of ACT‐774312: A novel CRTH2 antagonist. Basic & Clinical Pharmacology & Toxicology 124:6, pages 711-721.
Crossref
Crossref
Muriel Richard, Priska Kaufmann, Rüdiger Kornberger & Jasper Dingemanse. (2019)
First‐in‐man study of
ACT
‐709478, a novel selective triple T‐type calcium channel blocker
. Epilepsia 60:5, pages 968-978.
Crossref
Crossref
Nevin F. W. Zaki, Maha Yousif, Ahmed S. BaHammam, David Warren Spence, Vijay K. Bharti, Perumal Subramanian & Seithikurippu R. Pandi-Perumal. (2019) Chronotherapeutics: Recognizing the Importance of Timing Factors in the Treatment of Disease and Sleep Disorders. Clinical Neuropharmacology 42:3, pages 80-87.
Crossref
Crossref
Uma Kizhuveetil, Meghana V. Palukuri, Priyanshu Sharma, Devarajan Karunagaran, Raghunathan Rengaswamy & G. K. Suraishkumar. (2019) Entrainment of superoxide rhythm by menadione in HCT116 colon cancer cells. Scientific Reports 9:1.
Crossref
Crossref
Stephen J. Jones, Annette F. Taylor & Paul A Beales. (2018) Towards feedback-controlled nanomedicines for smart, adaptive delivery. Experimental Biology and Medicine 244:4, pages 283-293.
Crossref
Crossref
Keiichi ItohShoji MasumoriDaisuke MukaiHiroyuki Sakakibara, Michiko Yasuda & Kayoko Shimoi. (2019) Dosage time affects alkylating agents induced micronuclei in mouse peripheral blood reticulocytes through the function of erythropoietin. The Journal of Toxicological Sciences 44:4, pages 273-282.
Crossref
Crossref
N. P. Bowles, S. S. Thosar, M. X. Herzig & S. A. Shea. (2018) Chronotherapy for Hypertension. Current Hypertension Reports 20:11.
Crossref
Crossref
Shinji Kobuchi, Yukako Ito, Daiki Takamatsu & Toshiyuki Sakaeda. (2018) Circadian variations in the pharmacokinetics of the oral anticancer agent tegafur-uracil (UFT) and its metabolites in rats. European Journal of Pharmaceutical Sciences 123, pages 452-458.
Crossref
Crossref
Hiroshi Kawai, Natsumi Kodaira, Chika Tanaka, Takuya Ishibashi, Naomi Kudo, Yoichi Kawashima & Atsushi Mitsumoto. (2018) Time of Administration of Acute or Chronic Doses of Imipramine Affects its Antidepressant Action in Rats. Journal of Circadian Rhythms 16:1.
Crossref
Crossref
Booker T. DavisIVIV, Robin M. Voigt, Maliha Shaikh, Christopher B. Forsyth & Ali Keshavarzian. (2018) Circadian Mechanisms in Alcohol Use Disorder and Tissue Injury. Alcoholism: Clinical and Experimental Research 42:4, pages 668-677.
Crossref
Crossref
Stephanie Gängler, Pantelis Charisiadis, Ratanesh Seth, Saurabh Chatterjee & Konstantinos C. Makris. (2018) Time of the day dictates the variability of biomarkers of exposure to disinfection byproducts. Environment International 112, pages 33-40.
Crossref
Crossref
Shinji Kobuchi, Yukiko Yazaki, Yukako Ito & Toshiyuki Sakaeda. (2018) Circadian variations in the pharmacokinetics of capecitabine and its metabolites in rats. European Journal of Pharmaceutical Sciences 112, pages 152-158.
Crossref
Crossref
Makoto Tanaka, Yoshitaka Hashimoto, Chihiro Hasegawa, Steve Deacon & Richard Eastell. (2017) Antiresorptive effect of a cathepsin K inhibitor ONO-5334 and its relationship to BMD increase in a phase II trial for postmenopausal osteoporosis. BMC Musculoskeletal Disorders 18:1.
Crossref
Crossref
Yue ZhaoMin LiuXue Ying ChanSue Yee TanSharrada SubramaniamYong FanEva LohKenneth Tou En ChangThiam Chye Tan & Qingfeng Chen. (2017) Uncovering the mystery of opposite circadian rhythms between mouse and human leukocytes in humanized mice. Blood 130:18, pages 1995-2005.
Crossref
Crossref
Kevin J. Cyr, Omero M. Avaldi & John P. Wikswo. (2017)
Circadian hormone control in a human-on-a-chip:
In vitro
biology’s ignored component?
. Experimental Biology and Medicine 242:17, pages 1714-1731.
Crossref
Crossref
Fernanda Marques, João Carlos Sousa, Maria Alexandra Brito, Jens Pahnke, Cecilia Santos, Margarida Correia-Neves & Joana Almeida Palha. (2017) The choroid plexus in health and in disease: dialogues into and out of the brain. Neurobiology of Disease 107, pages 32-40.
Crossref
Crossref
Wafa Ben Cherif Khedhaier, Ichrak Dridi, Karim Aouam, Mossadok Ben-Attia, Alain Reinberg & Naceur A. Boughattas. (2017) Circadian variation in anticonvulsant activity of valproic acid in mice. Biomedicine & Pharmacotherapy 95, pages 25-30.
Crossref
Crossref
R. Kreutz, P.B. Persson, D. Kubitza, K. Thelen, S. Heitmeier, S. Schwers, M. Becka & M. Hemmrich. (2017) Dissociation between the pharmacokinetics and pharmacodynamics of once‐daily rivaroxaban and twice‐daily apixaban: a randomized crossover study. Journal of Thrombosis and Haemostasis 15:10, pages 2017-2028.
Crossref
Crossref
Ju-Hee Oh, Joo Hyun Lee, Dong-Hee Han, Sehyung Cho & Young-Joo Lee. (2017) Circadian Clock Is Involved in Regulation of Hepatobiliary Transport Mediated by Multidrug Resistance-Associated Protein 2. Journal of Pharmaceutical Sciences 106:9, pages 2491-2498.
Crossref
Crossref
R.H. Waring, R.M. Harris & S.C. Mitchell. (2017) Drug metabolism in the elderly: A multifactorial problem?. Maturitas 100, pages 27-32.
Crossref
Crossref
Yuanwei Huang, Qiuyan Yu, Yan Liu, Zhenli Zhu, Li Wang, Haidong Wang & Ke Li. (2017) Efficacy and safety of chronomodulated chemotherapy for patients with metastatic colorectal cancer: a systematic review and meta-analysis. Asia-Pacific Journal of Clinical Oncology 13:2, pages e171-e178.
Crossref
Crossref
O. Kalmykova, A. Pustovalov, I. Vareniuk & M. Dzerzhynsky. (2017) Effect of melatonin different time administration on the development of diet-induced obesity in rats. Bulletin of Taras Shevchenko National University of Kyiv. Series: Problems of Physiological Functions Regulation 23:2, pages 20-27.
Crossref
Crossref
F. Véronneau-Veilleux & J. Bélair. (2017) Modeling Circadian Fluctuations of Pharmacokinetic Parameters. Mathematical Modelling of Natural Phenomena 12:5, pages 146-161.
Crossref
Crossref
Ana Flo, Trinitat Cambras, Antoni Díez-Noguera & Ana Calpena. (2017) Melatonin pharmacokinetics after transdermal administration changes according to the time of the day. European Journal of Pharmaceutical Sciences 96, pages 164-170.
Crossref
Crossref
Stephen H. Curry & Robin Whelpton. 2016. Introduction to Drug Disposition and Pharmacokinetics. Introduction to Drug Disposition and Pharmacokinetics
211
232
.
Svetlana NikolaevaCamille Ansermet, Gabriel Centeno, Sylvain PradervandVincent Bize, David MordasiniHugues Henry, Robert Koesters, Marc MaillardOlivier BonnyNatsuko Tokonami & Dmitri Firsov. (2016) Nephron-Specific Deletion of Circadian Clock Gene Bmal1 Alters the Plasma and Renal Metabolome and Impairs Drug Disposition. Journal of the American Society of Nephrology 27:10, pages 2997-3004.
Crossref
Crossref
Julia M. Selfridge, Tetsuya Gotoh, Samuel Schiffhauer, JingJing Liu, Philip E. Stauffer, Andrew Li, Daniel G. S. Capelluto & Carla V. Finkielstein. (2016) Chronotherapy: Intuitive, Sound, Founded…But Not Broadly Applied. Drugs 76:16, pages 1507-1521.
Crossref
Crossref
Jiao Liu, Chun-Yan Wang, Song-Gang Ji, Xia Xu, Pei-Pei Wang, Bin Zhang, Li-Yan Zhao, Liang Liu, Ping-Ping Lin, Le-Kun Liu & Ming-Chun Li. (2015) Chronopharmacokinetics of Erlotinib and Circadian Rhythms of Related Metabolic Enzymes in Lewis Tumor-Bearing Mice. European Journal of Drug Metabolism and Pharmacokinetics 41:5, pages 627-635.
Crossref
Crossref
Clara Hartmanshenn, Megerle Scherholz & Ioannis P. Androulakis. (2016) Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine. Journal of Pharmacokinetics and Pharmacodynamics 43:5, pages 481-504.
Crossref
Crossref
Ariadna Amador, Salvador Huitron-Resendiz, Amanda J. Roberts, Theodore M. Kamenecka, Laura A. Solt & Thomas P. Burris. (2016) Pharmacological Targeting the REV-ERBs in Sleep/Wake Regulation. PLOS ONE 11:9, pages e0162452.
Crossref
Crossref
Yu Tahara & Shigenobu Shibata. (2016) Circadian rhythms of liver physiology and disease: experimental and clinical evidence. Nature Reviews Gastroenterology & Hepatology 13:4, pages 217-226.
Crossref
Crossref
Laura Kervezee, Jasper Stevens, Willem Birkhoff, Ingrid M. C. Kamerling, Theo de Boer, Melloney Dröge, Johanna H. Meijer & Jacobus Burggraaf. (2016) Identifying 24 h variation in the pharmacokinetics of levofloxacin: a population pharmacokinetic approach. British Journal of Clinical Pharmacology 81:2, pages 256-268.
Crossref
Crossref
R. Eastell, D.-J. Dijk, M. Small, A. Greenwood, J. Sharpe, H. Yamada, M. Yuba, M. Tanimoto & S. Deacon. (2015) Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial. Osteoporosis International 27:1, pages 309-318.
Crossref
Crossref
Khalid O Alfarouk, Christian-Martin Stock, Sophie Taylor, Megan Walsh, Abdel Khalig Muddathir, Daniel Verduzco, Adil H H Bashir, Osama Y Mohammed, Gamal O Elhassan, Salvador Harguindey, Stephan J Reshkin, Muntaser E Ibrahim & Cyril Rauch. (2015) Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp. Cancer Cell International 15:1.
Crossref
Crossref
Diego A. Golombek, Seithikurippu R. Pandi-Perumal, Gregory M. Brown & Daniel P. Cardinali. (2015) Some implications of melatonin use in chronopharmacology of insomnia. European Journal of Pharmacology 762, pages 42-48.
Crossref
Crossref
A van Rongen, L Kervezee, MJE Brill, H van Meir, J den Hartigh, H‐J Guchelaar, JH Meijer, J Burggraaf & F van Oosterhout. (2015) Population Pharmacokinetic Model Characterizing 24‐Hour Variation in the Pharmacokinetics of Oral and Intravenous Midazolam in Healthy Volunteers. CPT: Pharmacometrics & Systems Pharmacology 4:8, pages 454-464.
Crossref
Crossref
Lisette Binkhorst, Jacqueline S. L. Kloth, Annelieke S. de Wit, Peter de Bruijn, Mei H. Lam, Ines Chaves, Herman Burger, Robbert J. van Alphen, Paul Hamberg, Ron H. N. van Schaik, Agnes Jager, Birgit C. P. Koch, Erik A. C. Wiemer, Teun van Gelder, Gijsbertus T. J. van der Horst & Ron H. J. Mathijssen. (2015) Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients. Breast Cancer Research and Treatment 152:1, pages 119-128.
Crossref
Crossref
Hallie Kendis, Kelly Baron, Stephan U. Schuele, Bhavita Patel & Hrayr Attarian. (2015) Chronotypes in Patients with Epilepsy: Does the Type of Epilepsy Make a Difference?. Behavioural Neurology 2015, pages 1-4.
Crossref
Crossref
A. Hodor, S. Palchykova, B. Gao & C.L. Bassetti. (2015) Baclofen and gamma-hydroxybutyrate differentially altered behavior, EEG activity and sleep in rats. Neuroscience 284, pages 18-28.
Crossref
Crossref
Donghwan Lee, Hankil Son, Lay A. Lim & Kyungsoo Park. (2014) Population Pharmacokinetic Analysis of Diurnal and Seasonal Variations of Plasma Concentrations of Cilostazol in Healthy Volunteers. Therapeutic Drug Monitoring 36:6, pages 771-780.
Crossref
Crossref
I. Lares-Asse, P. Santiago-P, I. Chairez-He, G. Perez-Guil & H. Juarez-Olg. (2014) Effect of Growth and Development on Pharmacokinetics of Antipyrine in Swine. International Journal of Pharmacology 10:8, pages 519-523.
Crossref
Crossref
I. Robinson & A.B. Reddy. (2014) Molecular mechanisms of the circadian clockwork in mammals. FEBS Letters 588:15, pages 2477-2483.
Crossref
Crossref
Ichrak Dridi, Wafa Ben-Cherif, Karim Aouam, Mossadok Ben-Attia, Anis Klouz, Alain Reinberg & Naceur A. Boughattas. (2014) Circadian variation of mycophenolate mofetil pharmacokinetics in rats. European Journal of Pharmaceutical Sciences 58, pages 20-25.
Crossref
Crossref
Hans J. Tanke, Michel Zuiderwijk, Karien C. Wiesmeijer, Robert N. Breedveld, William R. Abrams, Claudia J. de Dood, Elisa M. Tjon Kon Fat & Paul L. A. M. Corstjens. The use of upconverting phosphors in point-of-care (POC) testing. The use of upconverting phosphors in point-of-care (POC) testing.
Shirin Bruderer, Noémie Hurst, Priska Kaufmann & Jasper Dingemanse. (2014) Multiple-Dose Up-Titration Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Selexipag, an Orally Available Selective Prostacyclin Receptor Agonist, in Healthy Subjects. Pharmacology 94:3-4, pages 148-156.
Crossref
Crossref
T. Mårtensson, P. Priftakis, T. Casswall, O. Ringdén, J. Mattsson, M. Remberger, M. Hassan & B. Gustafsson. (2013)
Increased risk of gastrointestinal acute
GVHD
following the addition of melphalan to busulfan/cyclophosphamide conditioning
. Pediatric Transplantation 17:3, pages 285-293.
Crossref
Crossref
Silke Conen, Eef L. Theunissen, Annemiek Vermeeren, Anke Sambeth & Johannes G. Ramaekers. (2013) Central Nervous System–Impairing Effects of Hydroxyzine as a Function of Histamine Availability. Journal of Clinical Psychopharmacology 33:2, pages 276-279.
Crossref
Crossref
Sriram Ramgopal, Sigride Thome-Souza & Tobias Loddenkemper. (2013) Chronopharmacology of Anti-Convulsive Therapy. Current Neurology and Neuroscience Reports 13:4.
Crossref
Crossref
Vidya Perera, Annette S Gross & Andrew J McLachlan. (2013) Diurnal variation in CYP1A2 enzyme activity in South Asians and Europeans. Journal of Pharmacy and Pharmacology 65:2, pages 264-270.
Crossref
Crossref
Helio Tedesco-Silva, Claudia Rosso Felipe, Alan Slade, Robert L. Schmouder & Jose Osmar Medina Pestana. (2012) Chronopharmacokinetics of Mycophenolic Acid and Its Glucuronide and Acyl Glucuronide Metabolites in Kidney Transplant Recipients Converted From Cyclosporine to Everolimus. Therapeutic Drug Monitoring 34:6, pages 652-659.
Crossref
Crossref
Alexander V. LyubimovRonald E. White. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
40
.
Petra Hoever, Sanne L de Haas, Georg Dorffner, Eleonora Chiossi, Joop M van Gerven & Jasper Dingemanse. (2012) Orexin receptor antagonism: an ascending multiple-dose study with almorexant. Journal of Psychopharmacology 26:8, pages 1071-1080.
Crossref
Crossref
H. Zahir, N. Matsushima, A.-B. Halim, L. He, G. Zhang, F. Lee, V. Worland & J. Mendell. (2012) Edoxaban administration following enoxaparin: A pharmacodynamic, pharmacokinetic, and tolerability assessment in human subjects. Thrombosis and Haemostasis 108:1, pages 166-175.
Crossref
Crossref
Ahmed M. Hamdan, Satoru Koyanagi, Erika Wada, Naoki Kusunose, Yuichi Murakami, Naoya Matsunaga & Shigehiro Ohdo. (2012) Intestinal Expression of Mouse Abcg2/Breast Cancer Resistance Protein (BCRP) Gene Is under Control of Circadian Clock-activating Transcription Factor-4 Pathway. Journal of Biological Chemistry 287:21, pages 17224-17231.
Crossref
Crossref
Francesco Portaluppi, Ruana Tiseo, Michael H. Smolensky, Ramón C. Hermida, Diana E. Ayala & Fabio Fabbian. (2012) Circadian rhythms and cardiovascular health. Sleep Medicine Reviews 16:2, pages 151-166.
Crossref
Crossref
Zuzana Kyselova. (2011) Toxicological aspects of the use of phenolic compounds in disease prevention. Interdisciplinary Toxicology 4:4, pages 173-183.
Crossref
Crossref
Donghwan Lee, Lay Ahyoung Lim, Seong Bok Jang, Yoon Jung Lee, Jae Yong Chung, Jong Rak Choi, Kiyoon Kim, Jin Woo Park, Hosang Yoon, Jaeyong Lee, Min Soo Park & Kyungsoo Park. (2011) Pharmacokinetic Comparison of Sustained- and Immediate-Release Oral Formulations of Cilostazol in Healthy Korean Subjects: A Randomized, Open-Label, 3-Part, Sequential, 2-Period, Crossover, Single-Dose, Food-Effect, and Multiple-Dose Study. Clinical Therapeutics 33:12, pages 2038-2053.
Crossref
Crossref
Jaime A. Yáñez, Dion R. Brocks, Laird M. Forrest & Neal M. Davies. 2011. Oral Bioavailability. Oral Bioavailability
183
219
.
Silke Conen, Eef L. Theunissen, Annemiek Vermeeren & Johannes G. Ramaekers. (2011) Short-Term Effects of Morning Versus Evening Dose of Hydroxyzine 50 mg on Cognition in Healthy Volunteers. Journal of Clinical Psychopharmacology 31:3, pages 294-301.
Crossref
Crossref
Alison H. Thomson & Henry L. Elliott. (2010) Designing simple PK–PD studies in children. Pediatric Anesthesia 21:3, pages 190-196.
Crossref
Crossref
Stephen H. Curry & Robin Whelpton. 2010. Drug Disposition and Pharmacokinetics. Drug Disposition and Pharmacokinetics
169
185
.
Dag Nyholm, Hans Lennernäs, Anders Johansson, Matias Estrada & Sten-Magnus Aquilonius. (2010) Circadian Rhythmicity in Levodopa Pharmacokinetics in Patients With Parkinson Disease. Clinical Neuropharmacology 33:4, pages 181-185.
Crossref
Crossref
R. D. LEE, D. MULFORD, J. WU & S. N. ATKINSON. (2010) The effect of time‐of‐day dosing on the pharmacokinetics and pharmacodynamics of dexlansoprazole MR: evidence for dosing flexibility with a Dual Delayed Release proton pump inhibitor. Alimentary Pharmacology & Therapeutics 31:9, pages 1001-1011.
Crossref
Crossref
Elena Llorente Fernández, Laura Parés, Iratxe Ajuria, Fernando Bandres, Bartomeu Castanyer, Francesc Campos, Carme Farré, Leonor Pou, Josep Maria Queraltó & Jordi To-Figueras. (2010) State of the art in therapeutic drug monitoring. cclm 48:4, pages 437-446.
Crossref
Crossref
Bimal K. Malhotra, Penelope H. Crownover, Robert LaBadie, Paul Glue & Scott A. MacDiarmid. (2009) The pharmacokinetic profile of fesoterodine 8 mg with daytime or nighttime dosing. European Journal of Clinical Pharmacology 66:2, pages 171-176.
Crossref
Crossref
C. Qvortrup, B.V. Jensen, T. Fokstuen, S.E. Nielsen, N. Keldsen, B. Glimelius, B. Bjerregaard, J. Mejer, F.O. Larsen & P. Pfeiffer. (2010) A randomized study comparing short-time infusion of oxaliplatin in combination with capecitabine XELOX30 and chronomodulated XELOX30 as first-line therapy in patients with advanced colorectal cancer. Annals of Oncology 21:1, pages 87-91.
Crossref
Crossref
Louisa A. Hooven, Katherine A. Sherman, Shawn Butcher & Jadwiga M. Giebultowicz. (2009) Does the Clock Make the Poison? Circadian Variation in Response to Pesticides. PLoS ONE 4:7, pages e6469.
Crossref
Crossref
Yu-Kun Jennifer Zhang, Ronnie L. Yeager & Curtis D. Klaassen. (2009) Circadian Expression Profiles of Drug-Processing Genes and Transcription Factors in Mouse Liver. Drug Metabolism and Disposition 37:1, pages 106-115.
Crossref
Crossref
Ronald A. Siegel. 2009. Chemomechanical Instabilities in Responsive Materials. Chemomechanical Instabilities in Responsive Materials
175
201
.
Konstantinos Makris, Elina Ioannou, Stavros Oikonomou, Nikolaos Efthymiou, Andria Constantinou, Thibault Delplancke & Pantelis Charisiadis. (2022) An Iso-Pesticide and Time-Restricted Dietary Intervention on the Biomarkers of Exposure to Pyrethroids and Neonicotonoid Pesticides: The Circa-Chem Cross-Over Randomized Trial. SSRN Electronic Journal.
Crossref
Crossref